After an earlier-than-expected FDA green light, Shionogi is rolling out COVID-19 antiviral Xocova with a tagline urging consumers to “make the call” on the pill after exposure. | Shionogi's “Got the Call, Make the Call” campaign for COVID antiviral Xocova kicks off with a TV ad depicting a mother getting a call from her COVID-infected son.

Shionogi Announces U.S. Availability of XOCOVA® (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure*

After an earlier-than-expected FDA green light, Shionogi is rolling out COVID-19 antiviral Xocova with a tagline urging consumers to “make the call” on the pill after exposure. |…